Discontinuation of Peritoneal Dialysis after Late Initiation of Eculizumab in a Case of Familial Atypical Hemolytic-Uremic Syndrome: A Case Report

BACKGROUND: Atypical hemolytic-uremic syndrome is caused by a thrombotic microangiopathy and manifests itself with hemolytic anemia, thrombocytopenia, and organ ischemia. Its etiology is a mutation affecting the genes encoding for proteins of the complement system. Early treatment with eculizumab (8...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso Valente, Rafael, García Rodríguez, Giannina Elena, García Marcote, Yanina, Fidalgo Díaz, Manuel, Becerra Mosquera, Vanesa, Novoa García, Daniel, Cordal Martínez, Teresa, Díaz Rodríguez, Cándido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465702/
https://www.ncbi.nlm.nih.gov/pubmed/28612003
http://dx.doi.org/10.1159/000457950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465702/
https://www.ncbi.nlm.nih.gov/pubmed/28612003
http://dx.doi.org/10.1159/000457950

Ejemplares similares